Labajo, Kyle Charmaine .

HRN: 23-93-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFUROXIME 500MG (TAB)
01/03/2024
01/09/2024
PO
500mg
BID
Thickly Msaf
Waiting Final Action 
01/03/2024
METRONIDAZOLE 500MG (TAB)
01/03/2024
01/09/2024
PO
1tab
TID
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: